|
2025
|
Invention
|
Modified microorganisms. The present invention relates to a live attenuated Gram-negative bacteri... |
|
|
Invention
|
Vacuole escape. The present invention relates to a live attenuated Gram-negative bacterium modifi... |
|
2024
|
Invention
|
Interleukin variant. There is provided an interleukin-21 (IL-21) variant, wherein in comparison t... |
|
|
Invention
|
Cancer therapy with live attenuated bacteria.
The present invention relates to the field of canc... |
|
|
Invention
|
Interleukin 15 variant. There is provided a bacterium comprising an interleukin-15 (IL-15) varian... |
|
|
Invention
|
Interleukin 18 variants. There is provided an interleukin-18 (IL-18) variant, wherein wild-type I... |
|
2023
|
Invention
|
Modified microorganisms. hlyCABDhlyCABDhlyAshlyAhlyhly genes involved in secretion. As such, the ... |
|
|
Invention
|
Bactofection. The present invention relates to a modified live attenuated Gram-negative bacteria,... |
|
|
Invention
|
Salmonella strain with chromosomally integrated landing pad. The present invention relates to a m... |
|
2022
|
Invention
|
Combination cancer therapy.
The present invention relates to the prevention and/or treatment of ... |
|
|
Invention
|
Combination cancer therapy. The present invention relates to the prevention and/or treatment of c... |
|
|
Invention
|
Cancer therapy. The present invention relates to the field of cancer therapy. In particular, the ... |
|
|
Invention
|
Cancer therapy with live attenuated bacteria. The present invention relates to the field of cance... |
|
2021
|
Invention
|
Autotransporter system.
The present invention provides for a modified autotransporter and the us... |
|
|
Invention
|
Autotransporter system. The present invention provides for a modified autotransporter and the use... |
|
2020
|
Invention
|
Modified strain of salmonella enterica typhi.
The present invention relates to the modification ... |
|
|
Invention
|
Salmonella enterica typhi. Salmonella entericaSalmonellaentericaSalmonella entericaSalmonella ent... |
|
|
Invention
|
Salmonella enterica typhi. salmonellosis. |
|
2018
|
Invention
|
Vaccine compositions ii. pltApltBcdtBtts ASalmonellaS. entericaS. entericaS. entericaS. entericap... |
|
|
Invention
|
Vaccine compositions. A genetically engineered non-natural bacterium comprising one or more of th... |
|
2013
|
Invention
|
Vaccines against clostridium difficile and methods of use.
Attenuated microorganisms expressing ... |
|
2012
|
G/S
|
Pharmaceutical, veterinary, prophylactic, and therapeutic preparations; vaccines. Scientific rese... |
|
2011
|
Invention
|
Self-deleting plasmid. A method of producing a selectable marker gene-free plasmid by culturing a... |
|
2010
|
Invention
|
Formulations of viable cells for oral delivery. This invention relates to solid formulations for ... |
|
2009
|
Invention
|
Use of e. coli surface antigen 3 sequences for the export of heterologous antigens.
The present ... |
|
2007
|
Invention
|
Identification of genes. (6) selecting an individual mutant which does not contain any of the mar... |
|
|
Invention
|
Attenuated salmonella sp12 mutants as antigen carriers. The present invention relates to vaccines... |
|
|
Invention
|
Attenuated microorganisms for the treatment of infection. Salmonella infection in a patient. |
|
2004
|
Invention
|
Salmonella sp12 mutants as antigen carriers. The present invention relates to vaccines, in partic... |
|
2000
|
Invention
|
Attenuated microorganisms for the treatment of infection. The present invention pertains to a Sal... |
|
1998
|
Invention
|
Identification of genes. A method for identifying a microorganism having a reduced adaptation to ... |
